Navigation Links
Active Life Announces Launch of Next Generation BioDentTM for Life Science Research
Date:9/18/2012

SANTA BARBARA, Calif., Sept. 18, 2012 /PRNewswire-iReach/ -- Active Life Scientific, Inc. announced today the launch of the next generation Reference Point Indenter, BioDentTM Hfc, to occur on October 12 at the 2012 American Society for Bone and Mineral Research (ASBMR) Annual Meeting in Minneapolis, Minnesota.

BioDentTM provides life science researchers previously impossible means to measure material properties of tissues in vivo.  "By listening to the needs of top life scientists world-wide, we developed a one-of-a-kind product for researchers," said Davis Brimer, Active Life's Chief Executive Officer.  "BioDentTM users are at the forefront of research and are quickly gaining a competitive edge in their field.  The next generation BioDentTM provides an excellent entry point for collecting increasingly important tissue-level material property data."

Applications are under development for measuring material properties of a multitude of tissues.  Initially, Active Life is focused on supporting bone tissue applications, making ASBMR an ideal launch location.  "Several key opinion leader BioDentTM users were selected to present their groundbreaking research at the conference," said Chris Mazzochi, PhD, Active Life's Field Applications Scientist. "These presentations highlight the growing value of Reference Point Indentation data in bone research.  The intuitive BioDentTM Hfc interface has enabled initial users to spend little time learning the technology, thereby maximizing their time collecting and reporting important results."

About Active Life

Active Life Scientific, Inc., a Santa Barbara, CA based company, is developing life science and medical tools for previously impossible in vivo measures of biological material properties through Reference Point Indentation (RPI).  RPI is renowned inventor Dr. Paul Hansma's most recent breakthrough designed to quantitatively measure properties that are directly related to biological tissue health and propensity to failure.  Initial applications include lab and clinical research of bone fracture risk and effects of osteoporosis treatments.  The Company is expanding its offerings to meet increasing customer demand for testing tissues in addition to bone.  Active Life's mission is to provide tools for measuring biological material properties in vivo to accelerate new strategies for the diagnosis and treatment of musculoskeletal diseases and disorders. 

Media Contact: Davis Brimer Active Life Scientific, Inc., +1.805.770.2600 x101, davis@activelifescientific.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Active Life Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
2. According to New Survey, Most Men are Not Proactive about Their Health Despite the Desire to Live Long Lives
3. Henry Schein Cares Disaster Relief Hotline is Active and Ready to Support Customers Affected by Hurricane Isaac
4. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
5. Cool Containers Introduces a Non-Dry Ice Active Container for Frozen Shipments
6. Med Ad News, PharmaLive and Pharmalot Announce the Pharma Interactive Conference in Princeton, NJ
7. How to Create Dynamic Interactive Social Learning Spaces
8. EJK Duisburg Becomes One of the Most Active SynCardia Certified Centers in Europe
9. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
10. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
11. United Seating & Mobility Completes Acquisition of Active American Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017 On Friday, ... NASDAQ Composite closed the trading session up 0.19%; the ... S&P 500 was down 0.08%. US markets made broad ... the day in green. Pre-market today, Stock-Callers.com reviews these ... N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group ...
(Date:3/27/2017)... March 27, 2017  Twist Bioscience, a company accelerating ... announced that it raised an additional $33 million. To ... million. "It is an exciting time ... reach and continue to deliver industry-leading gene volume to ... commented Emily M. Leproust, Ph.D., CEO of Twist Bioscience. ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology:
(Date:3/27/2017)... Georgia (PRWEB) , ... March 27, 2017 , ... ... to announce that for a second year in a row; they are the ... healthcare designers in the industry voted on the award at Design Connections 2017. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... Clearwater, Fla. (PRWEB) , ... March 27, 2017 , ... ... (1) and the number of homeowners utilizing DIY and unlicensed contractors for renovations is ... bathroom remodel or replacement project in 2015, and of those, 42% failed to use ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... soil, dredged material, and hazardous and non-hazardous materials announced today the acquisition of ... This acquisition will add four additional processing facilities and a vast array of ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... awards, now in their 12th year, are among the most prestigious in radiology marketing ... the awards were retooled to recognize achievements in both large budget (over $5,000) and ...
Breaking Medicine News(10 mins):